Predicting who will develop type 1 diabetes is now cheaper and more accessible, thanks to a new tool based on research conducted at the University of Exeter which could one day help determine who to target with recently approved drugs to delay…
Continue Reading
News Source: medicalxpress.com
Leave a Reply